Basel Medical Group Ltd O...

NASDAQ: BMGL · Real-Time Price · USD
2.02
-0.03 (-1.46%)
At close: Aug 15, 2025, 12:13 PM

Basel Medical Ltd Ordinary Shares Cash Flow Statement

Financials in SGD. Fiscal year is July - June.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022
Net Income
2.4M 2.13M 2.39M
Depreciation & Amortization
528.73K 557.13K 575.92K
Stock-Based Compensation
n/a n/a n/a
Other Working Capital
387.69K -223.96K 64.49K
Other Non-Cash Items
-419.19K -375.51K -251.26K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-4.82K 286.8K 81.37K
Operating Cash Flow
2.51M 2.6M 2.79M
Capital Expenditures
-7.92K -6.16K -88.5K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-7.92K -6.16K -88.5K
Debt Repayment
-2.92M -2.94M -2.06M
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
1.16M 325.00 -10.86M
Financial Cash Flow
-1.77M -2.94M -12.92M
Net Cash Flow
733.61K -346.24K -10.22M
Free Cash Flow
2.5M 2.59M 2.7M